Skip to main content
Top
Published in: BMC Public Health 1/2015

Open Access 01-12-2015 | Research article

Low prevalence of the transmitted HIV-1 drug resistance among newly diagnosed HIV-1 individuals in Jiangsu Province, China during 2009–2011

Authors: Hongxiong Guo, Xiaoqin Xu, Haiyang Hu, Ying Zhou, Haitao Yang, Tao Qiu, Gengfeng Fu, Xiping Huan

Published in: BMC Public Health | Issue 1/2015

Login to get access

Abstract

Background

Prevalence of The transmitted HIV drug resistance (THDR) has been reported in many countries. In China, the low level THDR was found in only a few provinces. To know the transmitted HIV drug resistance in east of China, we investigated THDR during 2009–2011 in Jiangsu province of China.

Methods

Between January and August of 2009, 2010, and 2011, we consecutively collected 50, 54, 53 blood specimens respectively from qualified individuals at surveillance sentinel sites in Jiangsu province according to protocol of HIV Drug Resistance Threshold Survey (HIVDR-TS) recommended by WHO. The region of pol gene including protease and partial retro-transcriptase was amplified, sequenced and edited. Then the sequences were submitted to HIV drug resistance database to analysis transmitted HIV drug resistance mutations using Calibrated Population Resistance tool. The reference sequences of different HIV-1 subtypes were downloaded from HIV database and Genebank. The phylogenetic trees were inferred using the neighbor-joining method.

Results

Our results show that THDR has been at low level from 2009 to 2011, only K101E and V179D mutation was detected which did not belong to the major HIV-1 drug resistance mutations. Phylogenetic analysis showed that CRF01_AE is the predominant subtype, and followed by CRF07_BC and B subtype. Subtype B consists of the two distinct clusters.

Conclusions

The low level of THDR suggests that anti-retroviral treatment was implemented more effectively and THDR surveillance should be conducted two years later in Jiangsu province of China. CRF01_AE has become the predominant subtype and dual infection of HIV may be common in Jiangsu province.
Literature
1.
go back to reference State Council AIDS Working Committee Office & UN Theme Group on AIDS in China. A joint assessment of HIV/AIDS Prevention, treatment and care in China (2009). Beijing: Ministry of Health of the People’s Republic of China; 2011. State Council AIDS Working Committee Office & UN Theme Group on AIDS in China. A joint assessment of HIV/AIDS Prevention, treatment and care in China (2009). Beijing: Ministry of Health of the People’s Republic of China; 2011.
2.
go back to reference Zhang F, Dou Z, Ma Y, Zhao Y, Liu Z, Bulterys M, et al. Five-year outcomes of the China National Free Antiretroviral Treatment Program. Ann Intern Med. 2009;151:241–51. W-252.CrossRefPubMed Zhang F, Dou Z, Ma Y, Zhao Y, Liu Z, Bulterys M, et al. Five-year outcomes of the China National Free Antiretroviral Treatment Program. Ann Intern Med. 2009;151:241–51. W-252.CrossRefPubMed
3.
go back to reference Zhang F, Dou Z, Ma Y, Zhang Y, Zhao Y, Zhao D, et al. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis. 2011;11:516–24.CrossRefPubMed Zhang F, Dou Z, Ma Y, Zhang Y, Zhao Y, Zhao D, et al. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis. 2011;11:516–24.CrossRefPubMed
4.
go back to reference Li J, Li H, Li L, Li H, Wang Z, Yang K, et al. Prevalence and evolution of drug resistance HIV-1 variants in Henan, China. Cell Res. 2005;15:843–9.CrossRefPubMed Li J, Li H, Li L, Li H, Wang Z, Yang K, et al. Prevalence and evolution of drug resistance HIV-1 variants in Henan, China. Cell Res. 2005;15:843–9.CrossRefPubMed
5.
go back to reference Huang D, Li Y, Tan W, Zheng C, Zhang Y, Gan Y, et al. Surveillance of primary drug resistance gene mutation for HIV infected men who have sex with men in Shenzhen in 2010. Mod Prev Med. 2013;403:521–3. Huang D, Li Y, Tan W, Zheng C, Zhang Y, Gan Y, et al. Surveillance of primary drug resistance gene mutation for HIV infected men who have sex with men in Shenzhen in 2010. Mod Prev Med. 2013;403:521–3.
6.
go back to reference Xie M, Yan Y, Yan P, Wu S, Chen G, Zhang C. Primary drug-resistant gene mutation to HIV-1 infected MSM in Fujian Province. Chinese J Zoonoses. 2013;29:27–30. Xie M, Yan Y, Yan P, Wu S, Chen G, Zhang C. Primary drug-resistant gene mutation to HIV-1 infected MSM in Fujian Province. Chinese J Zoonoses. 2013;29:27–30.
7.
go back to reference Han X, Zhao B, Sun F, An M, Yin L, Zhang H, et al. Primary HIV-1 drug resistance among injecting drug users in Xinjiang. Chinese J Public Health. 2012;28:810–1. Han X, Zhao B, Sun F, An M, Yin L, Zhang H, et al. Primary HIV-1 drug resistance among injecting drug users in Xinjiang. Chinese J Public Health. 2012;28:810–1.
8.
go back to reference Su X, Zhi J, Han J, Wu Y, Li X, Pei L, et al. HIV-1 subtypes and primary drug resistance among recently infected men who have sex with men in China. Int J Virol. 2012;19:146–50. Su X, Zhi J, Han J, Wu Y, Li X, Pei L, et al. HIV-1 subtypes and primary drug resistance among recently infected men who have sex with men in China. Int J Virol. 2012;19:146–50.
9.
go back to reference Xing H, Wang X, Liao L, Ma Y, Su B, Fu J, et al. HIV drug resistance and its impact on antiretroviral therapy in Chinese HIV-infected patients. Plos One. 2013;8:e54917.CrossRefPubMedPubMedCentral Xing H, Wang X, Liao L, Ma Y, Su B, Fu J, et al. HIV drug resistance and its impact on antiretroviral therapy in Chinese HIV-infected patients. Plos One. 2013;8:e54917.CrossRefPubMedPubMedCentral
10.
go back to reference Ndembi N, Lyagoba F, Nanteza B, Kushemererwa G, Serwanga J, Katongole-Mbidde E, et al. Transmitted antiretroviral drug resistance surveillance among newly HIV type 1-diagnosed women attending an antenatal clinic in Entebbe, Uganda. AIDS Res Hum Retroviruses. 2008;24:889–95.CrossRefPubMed Ndembi N, Lyagoba F, Nanteza B, Kushemererwa G, Serwanga J, Katongole-Mbidde E, et al. Transmitted antiretroviral drug resistance surveillance among newly HIV type 1-diagnosed women attending an antenatal clinic in Entebbe, Uganda. AIDS Res Hum Retroviruses. 2008;24:889–95.CrossRefPubMed
11.
go back to reference Ndembi N, Abraha A, Pilch H, Ichimura H, Mbanya D, Kaptue L, et al. Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaoundé, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. J Clin Microbiol. 2008;461:177–84.CrossRef Ndembi N, Abraha A, Pilch H, Ichimura H, Mbanya D, Kaptue L, et al. Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaoundé, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. J Clin Microbiol. 2008;461:177–84.CrossRef
12.
go back to reference Smith DM, Wong JK, Shao H, Hightower GK, Mai SH, Moreno JM, et al. Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission. J Infect Dis. 2007;196:356–60.CrossRefPubMed Smith DM, Wong JK, Shao H, Hightower GK, Mai SH, Moreno JM, et al. Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission. J Infect Dis. 2007;196:356–60.CrossRefPubMed
13.
go back to reference Hurt CB, McCoy SI, Kuruc J, Nelson JA, Kerkau M, Fiscus S, et al. Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina, 1998 to 2007. Antivir Ther. 2009;14:673–8.PubMedPubMedCentral Hurt CB, McCoy SI, Kuruc J, Nelson JA, Kerkau M, Fiscus S, et al. Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina, 1998 to 2007. Antivir Ther. 2009;14:673–8.PubMedPubMedCentral
14.
go back to reference Chen X, Xing H, Zhen J, Zhou S, Ruan Y, Qin B, et al. Study on the threshold of HIV-1 drug resistance in Hunan province. Chinese J Epidemiol. 2008;29:787–897. Chen X, Xing H, Zhen J, Zhou S, Ruan Y, Qin B, et al. Study on the threshold of HIV-1 drug resistance in Hunan province. Chinese J Epidemiol. 2008;29:787–897.
15.
go back to reference Yuan Y, Cao X, Liu H, Xing H, Liu C, Cui W, et al. Study on the transmission of drug resistant human immunodeficiency virus-1 in Henan province. China J Prev Med. 2009;43:956–9. Yuan Y, Cao X, Liu H, Xing H, Liu C, Cui W, et al. Study on the transmission of drug resistant human immunodeficiency virus-1 in Henan province. China J Prev Med. 2009;43:956–9.
16.
go back to reference Zhang J, Kang D, Lin B, Sun X, Fu J, Bi Z, et al. HIV type 1 virological response and prevalence of HIV type 1 drug resistance among patients receiving antiretroviral therapy, Shandong, China. AIDS Res Hum Retroviruses. 2012;28:1658–65.CrossRefPubMed Zhang J, Kang D, Lin B, Sun X, Fu J, Bi Z, et al. HIV type 1 virological response and prevalence of HIV type 1 drug resistance among patients receiving antiretroviral therapy, Shandong, China. AIDS Res Hum Retroviruses. 2012;28:1658–65.CrossRefPubMed
17.
go back to reference Xiao Z, Guo H, Fu GH, Li L, Xu X, Yang C, et al. Mutation of drug resistant gene in HIV infected patients with antiretroviral therapy in Jiangsu province. China J Public Health. 2011;27(suppl):14–6. Xiao Z, Guo H, Fu GH, Li L, Xu X, Yang C, et al. Mutation of drug resistant gene in HIV infected patients with antiretroviral therapy in Jiangsu province. China J Public Health. 2011;27(suppl):14–6.
19.
go back to reference Bennett DE, Myatt M, Bertagnolio S, Sutherland D, Gilks CF. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir Ther. 2008;13:25–36.PubMed Bennett DE, Myatt M, Bertagnolio S, Sutherland D, Gilks CF. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir Ther. 2008;13:25–36.PubMed
20.
go back to reference Myatt M, Bennett DE. A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings. Antivir Ther. 2008;13:37–48.PubMed Myatt M, Bennett DE. A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings. Antivir Ther. 2008;13:37–48.PubMed
21.
go back to reference Liao L, Xing H, Shang H, Li J, Zhong P, Cheng H, et al. The prevalence of transmitted antiretroviral drug resistance in treatment naïve HIV-infected individuals in China. J Acquir Immune Defic Syndr. 2010;53:S10–4.CrossRefPubMedPubMedCentral Liao L, Xing H, Shang H, Li J, Zhong P, Cheng H, et al. The prevalence of transmitted antiretroviral drug resistance in treatment naïve HIV-infected individuals in China. J Acquir Immune Defic Syndr. 2010;53:S10–4.CrossRefPubMedPubMedCentral
22.
go back to reference Su B, Liu L, Wang F, Gui X, Zhao M, Tien P, et al. HIV-1 subtype B’ dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China. AIDS. 2003;17:2515–20.CrossRefPubMed Su B, Liu L, Wang F, Gui X, Zhao M, Tien P, et al. HIV-1 subtype B’ dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China. AIDS. 2003;17:2515–20.CrossRefPubMed
23.
go back to reference Hao C, Lau JT, Zhao X, Yang H, Huan X, Yan H, et al. Associations between perceived characteristics of the peer social network involving significant others and risk of HIV transmission among men who have sex with men in China. AIDS Behav. 2014;18:99–110.CrossRefPubMed Hao C, Lau JT, Zhao X, Yang H, Huan X, Yan H, et al. Associations between perceived characteristics of the peer social network involving significant others and risk of HIV transmission among men who have sex with men in China. AIDS Behav. 2014;18:99–110.CrossRefPubMed
Metadata
Title
Low prevalence of the transmitted HIV-1 drug resistance among newly diagnosed HIV-1 individuals in Jiangsu Province, China during 2009–2011
Authors
Hongxiong Guo
Xiaoqin Xu
Haiyang Hu
Ying Zhou
Haitao Yang
Tao Qiu
Gengfeng Fu
Xiping Huan
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-1489-8

Other articles of this Issue 1/2015

BMC Public Health 1/2015 Go to the issue